Literature DB >> 24769209

Cholesterol-induced activation of TRPM7 regulates cell proliferation, migration, and viability of human prostate cells.

Yuyang Sun1, Pramod Sukumaran1, Archana Varma2, Susan Derry2, Abe E Sahmoun2, Brij B Singh3.   

Abstract

Cholesterol has been shown to promote cell proliferation/migration in many cells; however the mechanism(s) have not yet been fully identified. Here we demonstrate that cholesterol increases Ca(2+) entry via the TRPM7 channel, which promoted proliferation of prostate cells by inducing the activation of the AKT and/or the ERK pathway. Additionally, cholesterol mediated Ca(2+) entry induced calpain activity that showed a decrease in E-cadherin expression, which together could lead to migration of prostate cancer cells. An overexpression of TRPM7 significantly facilitated cholesterol dependent Ca(2+) entry, cell proliferation and tumor growth. Whereas, TRPM7 silencing or inhibition of cholesterol synthesis by statin showed a significant decrease in cholesterol-mediated activation of TRPM7, cell proliferation, and migration of prostate cancer cells. Consistent with these results, statin intake was inversely correlated with prostate cancer patients and increase in TRPM7 expression was observed in samples obtained from prostate cancer patients. Altogether, we provide evidence that cholesterol-mediated activation of TRPM7 is important for prostate cancer and have identified that TRPM7 could be essential for initiation and/or progression of prostate cancer.
Copyright © 2014. Published by Elsevier B.V.

Entities:  

Keywords:  Calcium and signal transduction; Cell proliferation and migration; Cholesterol; Prostate cancer; Statin; TRPM7

Mesh:

Substances:

Year:  2014        PMID: 24769209      PMCID: PMC4096426          DOI: 10.1016/j.bbamcr.2014.04.019

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  55 in total

Review 1.  Regulating cell migration: calpains make the cut.

Authors:  Santos J Franco; Anna Huttenlocher
Journal:  J Cell Sci       Date:  2005-09-01       Impact factor: 5.285

2.  Molecular determinants of Mg2+ and Ca2+ permeability and pH sensitivity in TRPM6 and TRPM7.

Authors:  Mingjiang Li; Jianyang Du; Jianmin Jiang; William Ratzan; Li-Ting Su; Loren W Runnels; Lixia Yue
Journal:  J Biol Chem       Date:  2007-06-28       Impact factor: 5.157

3.  Mg2+- and MgATP-inhibited and Ca2+/calmodulin-sensitive TRPM7-like current in hepatoma and hepatocytes.

Authors:  Ravi Mishra; Vidya Rao; Robert Ta; Navid Shobeiri; Ceredwyn E Hill
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-08-06       Impact factor: 4.052

Review 4.  The complex interplay between cholesterol and prostate malignancy.

Authors:  Keith R Solomon; Michael R Freeman
Journal:  Urol Clin North Am       Date:  2011-06-22       Impact factor: 2.241

Review 5.  Statins and protein prenylation in cancer cell biology and therapy.

Authors:  Carmen Garcia-Ruiz; Albert Morales; Jose C Fernandez-Checa
Journal:  Anticancer Agents Med Chem       Date:  2012-05       Impact factor: 2.505

6.  TRPC1 inhibits apoptotic cell degeneration induced by dopaminergic neurotoxin MPTP/MPP(+).

Authors:  Senthil Selvaraj; John A Watt; Brij B Singh
Journal:  Cell Calcium       Date:  2009-08-19       Impact factor: 6.817

Review 7.  CaMKK2: a novel target for shaping the androgen-regulated tumor ecosystem.

Authors:  Luigi Racioppi
Journal:  Trends Mol Med       Date:  2013-01-14       Impact factor: 11.951

Review 8.  Calcium and vitamin D supplementation during androgen deprivation therapy for prostate cancer: a critical review.

Authors:  Mridul Datta; Gary G Schwartz
Journal:  Oncologist       Date:  2012-07-25

9.  Statin use in relation to prostate cancer outcomes in a population-based patient cohort study.

Authors:  Milan S Geybels; Jonathan L Wright; Sarah K Holt; Suzanne Kolb; Ziding Feng; Janet L Stanford
Journal:  Prostate       Date:  2013-04-30       Impact factor: 4.104

10.  The role of calpain in the proteolytic cleavage of E-cadherin in prostate and mammary epithelial cells.

Authors:  Jonathan Rios-Doria; Kathleen C Day; Rainer Kuefer; Michael G Rashid; Arul M Chinnaiyan; Mark A Rubin; Mark L Day
Journal:  J Biol Chem       Date:  2002-10-19       Impact factor: 5.157

View more
  35 in total

1.  Suppression of TRPM7 inhibits proliferation, migration, and invasion of malignant human glioma cells.

Authors:  Tian-Dong Leng; Ming-Hua Li; Jian-Feng Shen; Ming-Li Liu; Xin-Bo Li; Hua-Wei Sun; Debbie Branigan; Zhao Zeng; Hong-Fang Si; Jun Li; Jeff Chen; Zhi-Gang Xiong
Journal:  CNS Neurosci Ther       Date:  2014-12-01       Impact factor: 5.243

2.  Lidocaine suppresses glioma cell proliferation by inhibiting TRPM7 channels.

Authors:  Tiandong Leng; Suizhen Lin; Zhigang Xiong; Jun Lin
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2017-04-15

3.  LXR agonist treatment of blastic plasmacytoid dendritic cell neoplasm restores cholesterol efflux and triggers apoptosis.

Authors:  Adam Ceroi; David Masson; Anne Roggy; Christophe Roumier; Cécile Chagué; Thierry Gauthier; Laure Philippe; Baptiste Lamarthée; Fanny Angelot-Delettre; Francis Bonnefoy; Sylvain Perruche; Sabeha Biichle; Claude Preudhomme; Elisabeth Macintyre; Laurent Lagrost; Francine Garnache-Ottou; Philippe Saas
Journal:  Blood       Date:  2016-10-04       Impact factor: 22.113

4.  TRPM7 channel inhibition mediates midazolam-induced proliferation loss in human malignant glioma.

Authors:  Jingkao Chen; Yunling Dou; Xiaoke Zheng; Tiandong Leng; Xiaofang Lu; Ying Ouyang; Huawei Sun; Fan Xing; Jialuo Mai; Jiayu Gu; Bingzheng Lu; Guangmei Yan; Jun Lin; Wenbo Zhu
Journal:  Tumour Biol       Date:  2016-09-14

5.  Racial Differences in the Association Between Preoperative Serum Cholesterol and Prostate Cancer Recurrence: Results from the SEARCH Database.

Authors:  Emma H Allott; Lauren E Howard; William J Aronson; Martha K Terris; Christopher J Kane; Christopher L Amling; Matthew R Cooperberg; Stephen J Freedland
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-01-25       Impact factor: 4.254

6.  Dopaminergic neurotoxins induce cell death by attenuating NF-κB-mediated regulation of TRPC1 expression and autophagy.

Authors:  Pramod Sukumaran; Yuyang Sun; Neil Antonson; Brij B Singh
Journal:  FASEB J       Date:  2018-01-03       Impact factor: 5.191

7.  TRPM2 Promotes Neurotoxin MPP+/MPTP-Induced Cell Death.

Authors:  Yuyang Sun; Pramod Sukumaran; Senthil Selvaraj; Nicholas I Cilz; Anne Schaar; Saobo Lei; Brij B Singh
Journal:  Mol Neurobiol       Date:  2016-12-12       Impact factor: 5.590

8.  Mibefradil represents a new class of benzimidazole TRPM7 channel agonists.

Authors:  Sebastian Schäfer; Silvia Ferioli; Thomas Hofmann; Susanna Zierler; Thomas Gudermann; Vladimir Chubanov
Journal:  Pflugers Arch       Date:  2015-12-16       Impact factor: 3.657

9.  The association of statin subgroups with lower urinary tract symptoms following a prostate biopsy.

Authors:  Hanan Goldberg; Faizan K Mohsin; Thenappan Chandrasekar; Christopher J D Wallis; Zachary Klaassen; Ardalan E Ahmad; Refik Saskin; Miran Kenk; Olli Saarela; Girish S Kulkarni; Shabbir M H Alibhai; Neil Fleshner
Journal:  Can Urol Assoc J       Date:  2022-05       Impact factor: 2.052

Review 10.  Ion Channel Profiling in Prostate Cancer: Toward Cell Population-Specific Screening.

Authors:  Valerio Farfariello; Natalia Prevarskaya; Dimitra Gkika
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.